Website intended for a NZ health professional readership
This article describes local research into the experiences of families with a young child needing repeated hospitalisations for lower respiratory infections. These families face numerous challenges, and action plans would help
1. Trenholme AA, Byrnes CA, McBride C, et al. Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection. Pediatr Pulmonol 2013;48(8):772–79.
2. Craig E, Anderson P, Jackson C. The Health Status of Children and Young People in Counties Manukau. Auckland UniServices Limited; 2008. https://bit.ly/3sEGHQ1
3. McBride-Henry K, Miller C, Trenholm A, et al. Occupying ‘in-hospitable’ spaces: Parental/primary-caregiver perceptions of the impact of repeated hospitalisation in children under two years of age. PLoS ONE 2020;15(1):e0228354.
4. Singleton RJ, Redding GJ, Lewis TC, et al. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska native children. Pediatrics 2003;112(2):285–90.
5. Valery PC, Torzillo PJ, Mulholland K, et al. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 2004;23(10):902–8.
6. McBride-Henry K, Miller C, Trenholm A, et al. ‘You have to do what is best’: The lived reality of having a child who is repeatedly hospitalized because of acute lower respiratory infection. Health Expect 2021; 20 December online.
7. Oranga Tamariki. Family Start Programme Manual. Oranga Tamariki, Ministry for Children, New Zealand Government; 2021. https://bit.ly/3sEGTyY
8. Agrawal SK, Singh M, Mathew JL, et al. Efficacy of an individualized written home-management plan in the control of moderate persistent asthma: a randomized, controlled trial. Acta Paediatr 2005;94:1742–46.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
